Ian Tagge1, Daniel Schwartz1, Katherine Powers1, Rohit Bakshi2, Peter Calabresi3, Todd Constable4, John Grinstead1,5, Roland Henry6, Govind Nair7, Jiwon Oh3,8, Li Pan9, Nico Papinutto6, Daniel Pelletier10, Daniel S Reich7, Nancy Sicotte10, Jack Simon1, William Stern6, and William Rooney11
1Advanced Imaging Research Center, Oregon Health & Science University, Portland, OR, United States, 2Brigham & Women's Hospital, Harvard Medical School, 3Johns Hopkins, 4Yale, 5Siemens Medical Solutions, Portland, OR, 6University of California San Francisco, 7National Institute of Neurological Disease and Stroke, National Institute of Health, 8University of Toronto, 9Siemens Healthcare, Baltimore, MD, 10University of Southern California, Keck School of Medicine, 11Oregon Health & Science University, Portland, OR, United States
Synopsis
The current lack of standardization in MRI protocols
leads to increased variability, particularly in semi-quantitative techniques
such as MTR, and makes comparisons between studies almost impossible. A single
subject with clinically stable RRMS travelled to seven North American sites and
underwent two distinct 3T MRI sessions following a standardized MTR and qT1
protocol at each site. Both MTR and qT1 mapping have been shown to
have potential in elucidating tissue characteristics and underlying pathology. This
work demonstrated that use of carefully standardized protocols produces
consistent quantitative and semi-quantitative measurements across sites in MS
brain tissue in-vivo.
Introduction
The
North American Imaging in Multiple Sclerosis (NAIMS) Cooperative was formed
with the goal of developing sensitive, reliable imaging-based surrogates for
disease progression in MS. The results of these efforts will accelerate MS
research by creating standardized quantitative imaging protocols, a centralized
database, multiple analytic tools, and data sharing across NAIMS sites.Methods
A
single subject with clinically stable RRMS traveled to seven North American
sites and underwent two distinct 3T MRI sessions following a standardized
protocol at each site. Informed consent was obtained at each imaging center.
The variable flip angle (FA) method (FA 3°, 6°, 10°,
20°) was employed to create whole-brain
quantitative T1 (qT1) maps. Magnetization transfer images
were acquired with two saturation pulse offset frequencies (4kHz, 100kHz) at 8 mT amplitude, sufficient for magnetization
transfer ratio (MTR) calculation. Tissue and lesion segmentation was achieved
using LesionTOADS software.1,2 Lesion masks were manually edited as necessary.Results
Imaging
sessions were successfully completed at all sites between October 2015 and
February 2016. Mean (±standard deviation) white matter, cortical grey matter,
and lesion MTR and R1 (≡1/T1) values for all imaging
sessions are shown in Table 1. Mean intra-session MTR variance was 0.0001 across
all sites and demonstrated good correlation as illustrated in Figure 1. MTR
maps were of similar quality (characterized by signal-to-noise ratio, homogeneity)
across all sites and are shown in Figure 2. Despite applying corrections, B1
inhomogeneity contributed to substantial inconsistencies in qT1 maps
(Figure 3), particularly in the most superior and inferior regions of the brain
where radio frequency coil performance is variable and sensitive to subject
placement within the instrument. Discussion
Both MTR and qT1 mapping
have been shown to have potential in elucidating tissue characteristics and
underlying pathology.3-6 MTR is effectively a self-bias-correcting technique and
demonstrated greater reproducibility across sites than did qT1 mapping.
The current lack of standardization in MRI protocols leads to increased
variability, particularly in semi-quantitative techniques such as MTR, and
makes comparisons between studies almost impossible. This work demonstrated
that use of carefully standardized protocols produces consistent quantitative
and semi-quantitative measurements across sites in MS brain tissue in-vivo. Future
work will combine the qT1 and MTR maps for quantitative calculations
of macromolecular fraction.Acknowledgements
Funding provided by Race to Erase MS.
This work has been submitted on behalf of the NAIMS Consortium
References
1. Shiee, N. et al. A
topology-preserving approach to the segmentation of brain images with multiple
sclerosis lesions. Neuroimage 2010;49(2):1524–1535 .
2. Shiee, N. et al. Revisiting
brain atrophy and its relationship to disability in multiple sclerosis. PLoS
One 2012;7(5):e37049
3. Mottershead, J. P. et al. High
field MRI correlates of myelin content and axonal density in multiple
sclerosis: A post-mortem study of the spinal cord. J. Neurol. 250,
1293–1301 (2003).
4. Bonnier, G. et al.
Multicontrast MRI Quantification of Focal Inflammation and Degeneration in
Multiple Sclerosis. Biomed Res. Int. 2015, 569123 (2015).
5. Al-Radaideh, A. et al.
Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in
clinically isolated syndrome and relapsing-remitting multiple sclerosis. NMR
Biomed. 28, 1374–1382 (2015).
6. Tagge, I. et al.
Spatio-Temporal Patterns of Demyelination and Remyelination in the Cuprizone
Mouse Model. PLoS One 11, e0152480 (2016).